Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The trial objectives were to investigate the tolerability and pharmacokinetics of 80 mg
telmisartan and 2, 4 or 6 mg lacidipine administered concurrently.